abstract |
The present invention relates to a compound or a pharmaceutically acceptable salt of formula (I), Wherein A 1 , A 2 , A 3 , A 4 , X and Y are as defined in the specification. The invention also relates to methods of making said compounds, and compositions containing said compounds useful for inhibiting kinases such as Aurora and KDR. |